TREA

Jinwang Xu

Follow

Person

  • Framingham, MA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 12,005,127
    • Issue date Jun 11, 2024
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Modulators of alpha-1 antitrypsin
    • Patent number 11,884,672
    • Issue date Jan 30, 2024
    • Vertex Pharmaceuticals Incorporated
    • Upul Keerthi Bandarage
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 11,813,267
    • Issue date Nov 14, 2023
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Modulators of alpha-1 antitrypsin
    • Patent number 11,623,924
    • Issue date Apr 11, 2023
    • Vertex Pharmaceuticals Incorporated
    • Upul Keerthi Bandarage
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 11,021,465
    • Issue date Jun 1, 2021
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 11,008,305
    • Issue date May 18, 2021
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted quinoxaline DNA-PK inhibitors
    • Patent number 10,973,830
    • Issue date Apr 13, 2021
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,786,512
    • Issue date Sep 29, 2020
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,501,439
    • Issue date Dec 10, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,442,791
    • Issue date Oct 15, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,391,095
    • Issue date Aug 27, 2019
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,258,627
    • Issue date Apr 16, 2019
    • Vertex Pharmaceutical Incorporated
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 10,076,521
    • Issue date Sep 18, 2018
    • Vertex Pharamceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted benzooxadiazole DNA-PK inhibitors
    • Patent number 9,987,284
    • Issue date Jun 5, 2018
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors and uses thereof
    • Patent number 9,925,188
    • Issue date Mar 27, 2018
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors for treatment of cancer
    • Patent number 9,878,993
    • Issue date Jan 30, 2018
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 9,592,232
    • Issue date Mar 14, 2017
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 9,376,448
    • Issue date Jun 28, 2016
    • Vertex Pharmaceuticals Incorporated
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 9,359,380
    • Issue date Jun 7, 2016
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Substituted quinoxaline DNA-PK inhibitors
    • Patent number 9,340,557
    • Issue date May 17, 2016
    • Vertex Pharmaceuticals Incorporated
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    DNA-PK inhibitors
    • Patent number 9,296,701
    • Issue date Mar 29, 2016
    • Vertex Pharmaceuticals Incorporated
    • Paul S Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
    • Patent number 8,524,906
    • Issue date Sep 3, 2013
    • Vertex Pharmaceuticals Incorporated
    • Alex Aronov
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Inhibitors of phosphatidylinositol 3-kinase
    • Patent number 8,344,153
    • Issue date Jan 1, 2013
    • Vertex Pharmaceuticals Incorporated
    • Kevin Michael Cottrell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Modulators of muscarinic receptors
    • Patent number 8,304,423
    • Issue date Nov 6, 2012
    • Vertex Pharmaceutical Incorporated
    • Robert J. Davies
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    c-MET protein kinase inhibitors
    • Patent number 8,232,406
    • Issue date Jul 31, 2012
    • Vertex Pharmaceuticals Incorporated
    • David J. Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Modulators of muscarinic receptors
    • Patent number 7,973,162
    • Issue date Jul 5, 2011
    • Vertex Pharmaceuticals Incorporated
    • Robert J. Davies
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Diaminotriazoles useful as inhibitors of protein kinases
    • Patent number 7,902,239
    • Issue date Mar 8, 2011
    • Vertex Pharmaceuticals Incorporated
    • Albert C. Pierce
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    c-MET protein kinase inhibitors
    • Patent number 7,872,031
    • Issue date Jan 18, 2011
    • Vertex Pharmaceuticals Incorporated
    • David J. Lauffer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Modulators of muscarinic receptors
    • Patent number 7,858,790
    • Issue date Dec 28, 2010
    • Vertex Pharmaceuticals Incorporated
    • Upul K. Bandarage
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Modulators of muscarinic receptors
    • Patent number 7,786,107
    • Issue date Aug 31, 2010
    • Vertex Pharmaceuticals Incorporated
    • Robert J. Davies
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    MODULATORS OF ALPHA-1 ANTITRYPSIN
    • Publication number 20240336614
    • Publication date Oct 10, 2024
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Upul Keerthi BANDARAGE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MODULATORS OF ALPHA-1 ANTITRYPSIN
    • Publication number 20230339915
    • Publication date Oct 26, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Simon GIROUX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS
    • Publication number 20230277547
    • Publication date Sep 7, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MODULATORS OF ALPHA-1 ANTITRYPSIN
    • Publication number 20230265080
    • Publication date Aug 24, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Upul Keerthi BANDARAGE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    1H-PYRAZOLO[4,3-G]ISOQUINOLINE AND 1H-PYRAZOLO[4,3-G]QUINOLINE DERI...
    • Publication number 20230159521
    • Publication date May 25, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Simon GIROUX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODE...
    • Publication number 20230159580
    • Publication date May 25, 2023
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Simon GIROUX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED QUINOXALINE DNA-PK INHIBITORS
    • Publication number 20210236505
    • Publication date Aug 5, 2021
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MODULATORS OF ALPHA-1 ANTITRYPSIN
    • Publication number 20210179587
    • Publication date Jun 17, 2021
    • Vertex Pharmaceuticals Incorporated
    • Upul Keerthi BANDARAGE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20210069203
    • Publication date Mar 11, 2021
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MODULATORS OF ALPHA-1 ANTITRYPSIN
    • Publication number 20200361939
    • Publication date Nov 19, 2020
    • Vertex Pharmaceuticals Incorporated
    • Upul Keerthi BANDARAGE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20200353101
    • Publication date Nov 12, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick MAXWELL
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20200109130
    • Publication date Apr 9, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20200062732
    • Publication date Feb 27, 2020
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20190290654
    • Publication date Sep 26, 2019
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20190255062
    • Publication date Aug 22, 2019
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180325898
    • Publication date Nov 15, 2018
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180311254
    • Publication date Nov 1, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180208579
    • Publication date Jul 26, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180193341
    • Publication date Jul 12, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20180161336
    • Publication date Jun 14, 2018
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20170258789
    • Publication date Sep 14, 2017
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20160368899
    • Publication date Dec 22, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20160354381
    • Publication date Dec 8, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20160340341
    • Publication date Nov 24, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • John Patrick Maxwell
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20160250212
    • Publication date Sep 1, 2016
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20150111871
    • Publication date Apr 23, 2015
    • VERTEX PHARMACEUTICALS INCORPORATED
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20140045869
    • Publication date Feb 13, 2014
    • Paul S. Charifson
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    DNA-PK INHIBITORS
    • Publication number 20130281431
    • Publication date Oct 24, 2013
    • Paul S. Charifson
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TETRAHYDROTHIAZOLOPYRIDINE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
    • Publication number 20120039849
    • Publication date Feb 16, 2012
    • Vertex Pharmaceuticals Incorporated.
    • Alex Aronov
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    C-MET PROTEIN KINASE INHIBITORS
    • Publication number 20110059936
    • Publication date Mar 10, 2011
    • Vertex Pharmaceuticals Incorporated.
    • David J. Lauffer
    • C07 - ORGANIC CHEMISTRY